Additional examination of SDHA expression in both immune and molecular BC subtypes was performed, demonstrating a rise in SDHA expression, particularly in HER2-positive BC subtypes (Fig. 1C), and notable variations across the five immune subtypes (Fig. 1D). Here, ERBB2 is linked to breast cancer.